Maxy-G34

· Maxygen Holdings Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Maxy-G34, covering 2007-12-24 to 2007-12-24. Get the full timeline:

Most recent: Clinical Trial Update: Evaluation of Maxy-G34 in Breast Cancer Patients Treated With TAC (Docetaxel, Adriamycin, Cyclophosphamide) Chemotherapy [Phase 2]

See pricing